Γ

SynBioBeta Speaker

Celestine Schnugg

Boom Capital

Founding Managing Partner

Celestine "Cee Cee" Schnugg is a Silicon Valley venture capitalist and the Founding Managing Partner of Boom Capital, an early stage venture firm financing scientists and engineers. She is the first investor in Mammoth Biosciences, A-Alpha Bio, Fauna Bio, and Diligent Robotics, and early rounds of Swarm Technologies (acquired by SpaceX), Astra (NASDAQ: ASTR), Planet (NYSE: PL) Impulse Space, and Galileo Health. Prior to Boom, she was at Eric Schmidt's Innovation Endeavors. Prior to Innovation Endeavors, she helped build the sustainability program at Apple. She has led global innovation initiatives with NASA and the White House and is the creator of Curiosity Camp and National Day of Civic Hacking. Celestine is on the Investment Committee of the Goldhirsh Foundation and was an Innovation Advisor to British Airways. Driven by the belief that no child should bear the weight of an untreatable disease, Cee Cee founded Project Atlas, a foundation accelerating translational research for cancer interception and rare pediatric conditions. Through Rare Team 6, a multidisciplinary operative, she leads efforts to uncover the biological drivers of undiagnosed conditions and build disease-specific biobanks-harnessing the decade's most powerful technologies to cure the incurable by 2035. At Boom Capital, she not only invests inception capital but convenes a scientific society of the top 200 technologists of the 21st century.

Sessions Featuring

Celestine

This Year

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include